Titelia

Funds holding BARINTHUS BIOTHERAPEUTICS PLC

ISIN US91864C1071 · United Kingdom · LEI 213800KQ9EAOKPWN8A33

Fund holders
1
Of which ETFs
0 1 other fund
Value held
6.8K $

A single tracked fund declares this company. So these figures do not say who owns it.

FundSharesValueWeight in fund
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 11,5686.8K $as of Feb 28, 2026

Download this table: CSV, JSON

Report an error

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterHoldersChangeSharesChange
2026Q21011,5680.0 %
2026Q11011,5680.0 %
2025Q41011,5680.0 %
2025Q31011,5680.0 %
2025Q21011,5680.0 %
2025Q11011,5680.0 %
2024Q41-111,568-1.1 %
2024Q32011,692-17.0 %
2024Q22014,091+17.5 %
2024Q12+111,988+52.1 %
2023Q417,880

Institutional managers

14 managers declare this company to the SEC (Form 13F).

ManagerSharesValue
M&G PLC5,197,3495.2M $as of Mar 31, 2026
HSG Holding Ltd1,420,4731.2M $as of Mar 31, 2026
GLR Partners, LLC1,243,377707.5K $as of Mar 31, 2026
DC Funds, LP642,204365.4K $as of Mar 31, 2026
Rangeley Capital, LLC159,46590.7K $as of Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC151,00085.9K $as of Mar 31, 2026
Johns Hopkins University122,23769.6K $as of Mar 31, 2026
CITADEL ADVISORS LLC118,99668.1K $as of Mar 31, 2026
Baird Financial Group, Inc.105,96160.3K $as of Mar 31, 2026
GTS SECURITIES LLC73,21041.9K $as of Mar 31, 2026
HighTower Advisors, LLC37,45021.3K $as of Mar 31, 2026
RHUMBLINE ADVISERS11,6856.7K $as of Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC11,5686.6K $as of Mar 31, 2026
MORGAN STANLEY2,2101.3K $as of Mar 31, 2026

Declared shareholders of BARINTHUS BIOTHERAPEUTICS PLC

There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.

ShareholderDeclared stakeShares
International Generosity Foundation Trust 6.70 %2,734,189as of Feb 3, 2026 · SCHEDULE 13D
Cite this page

Titelia. "Funds holding BARINTHUS BIOTHERAPEUTICS PLC". https://titelia.com/en/stocks/barinthus-biotherapeutics-plc-US91864C1071